| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 102 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 89 |
| 2 | TACROLIMUS OINTMENT 0.1% | 87 |
| 3 | PREDNISONE | 73 |
| 4 | MYCOPHENOLATE MOFETIL | 62 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 62 |
| 6 | RITUXIMAB | 33 |
| 7 | METHYLPREDNISOLONE | 32 |
| 8 | MYCOPHENOLIC ACID | 26 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTOSTATIN | 3 | 0.0029 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 23 | 0.0028 |
| 2 | BELATACEPT | 11 | 0.0023 |
| 3 | BASILIXIMAB | 20 | 0.0017 |
| 4 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 5 | MYCOPHENILIC ACID | 20 | 0.0009 |
| 6 | MYCOPHENOLIC ACID | 26 | 0.0008 |
| 7 | VALGANCICLOVIR | 14 | 0.0007 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 89 | 0.0007 |
| 9 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 11 | 0.0023 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 20 | 0.0009 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 14 | 0.0006 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 5 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 6 | Complement Inhibitor [EPC] | 12 | 0.0002 |
| 7 | Polyene Antifungal [EPC] | 8 | 0.0002 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 9 | Proteasome Inhibitor [EPC] | 17 | 0.0001 |